review · 2006
A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder
57 citationsDOI: https://doi.org/10.1016/j.euroneuro.2006.05.001